Addpharma Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2018
NCT03586037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Addpharma Inc.